Press Releases on November 3, 2022 - EIN Presswire - Press Release Distribution Service

Published on November 3, 2022 - 20:01 GMT

Mulvihill Premium Yield Fund Declares Monthly Fund Distribution For its ETF Class

TORONTO, Nov. 03, 2022 (GLOBE NEWSWIRE) -- (TSX: MPY) Mulvihill Premium Yield Fund has declared a monthly fund distribution for its ETF Class in the amount of $0.04667 per unit, payable on December 7, 2022 to unitholders of record on November 30, 2022. For …

Distribution channels: Banking, Finance & Investment Industry

Published on November 3, 2022 - 20:01 GMT

Mulvihill Canadian Bank Enhanced Yield ETF Declares Monthly Distribution

TORONTO, Nov. 03, 2022 (GLOBE NEWSWIRE) -- (TSX: CBNK) Mulvihill Canadian Bank Enhanced Yield ETF has declared a monthly fund distribution in the amount of $0.058333 per unit, payable on December 7, 2022 to unitholders of record on November 30, 2022. For …

Distribution channels: Banking, Finance & Investment Industry

Published on November 3, 2022 - 20:01 GMT

Teknova to Participate in Upcoming Investor Conferences

HOLLISTER, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, research, development, and commercialization of drug therapies, novel vaccines, and molecular …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on November 3, 2022 - 20:01 GMT

Freeline Reports October 2022 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LONDON, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that on October 31, 2022, the Company granted three newly hired employees non-statutory options to purchase an aggregate of 75,500 of the Company’s …

Distribution channels: Banking, Finance & Investment Industry, Technology ...

Published on November 3, 2022 - 20:01 GMT

MacroGenics Provides Corporate Update and Third Quarter 2022 Financial Results

Collaboration with Gilead to develop bispecific antibodies, including MGD024, announced Planned initiation of Phase 2 portion of MGC018 TAMARACK study in prostate cancer by year-end Anticipated update on lorigerlimab (PD-1 × CTLA-4 bispecific DART® …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 3, 2022 - 20:01 GMT

NV5 Announces Record Third Quarter Results; Exceeds Analyst Consensus

HOLLYWOOD, Fla., Nov. 03, 2022 (GLOBE NEWSWIRE) -- NV5 Global, Inc. (Nasdaq: NVEE) ("NV5" or the "Company"), a provider of technology, conformity assessment, and consulting solutions, today reported financial results for the third …

Distribution channels: Business & Economy, Technology ...

Published on November 3, 2022 - 20:01 GMT

Fate Therapeutics Reports Third Quarter 2022 Financial Results and Highlights Operational Progress

FT596+R Enrollment Ongoing in Three-dose Escalation Cohort for R/R BCL; Activating Community Sites for Investigation of FT596+R-CHOP in Newly-diagnosed Patients with Aggressive BCL Positive Feedback Received from FDA under FT516 RMAT Designation for …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 3, 2022 - 20:01 GMT

Miromatrix to Report Third Quarter 2022 Financial Results

EDEN PRAIRIE, Minn., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on November 3, 2022 - 20:01 GMT

BioAtla Reports Third Quarter 2022 Financial Results and Highlights Recent Progress

Mecbotamab vedotin (BA3011) Phase 2 part 1 interim results in NSCLC continue to show antitumor activity with additional patients enrolled BA3011 Undifferentiated Pleomorphic Sarcoma (UPS) enrollment in Phase 2 part 2 of study anticipated to begin by year- …

Distribution channels: Business & Economy, Technology ...

Published on November 3, 2022 - 20:01 GMT

Codiak BioSciences Reports Third Quarter 2022 Financial Results and Operational Progress

– Patient enrollment continuing in Phase 1 clinical trial of exoASO™-STAT6 in patients with advanced hepatocellular carcinoma; preliminary data anticipated during 1H 2023 – – Presented preclinical data showing exoVACC™ pan beta coronavirus vaccine, …

Distribution channels: Business & Economy, Technology ...

Published on November 3, 2022 - 20:01 GMT

Silvercrest Asset Management Group Inc. Reports Q3 2022 Results

NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Silvercrest Asset Management Group Inc. (NASDAQ: SAMG) (the “Company” or “Silvercrest”) today reported the results of its operations for the quarter ended September 30, 2022. Business Update Volatile market …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on November 3, 2022 - 20:01 GMT

Bionano Genomics Reports Third Quarter 2022 Financial Results and Highlights Recent Business Progress

– 55% year-over-year revenue growth in Q3 2022 – On track to achieve all 2022 ELEVATE! milestones – Strong balance sheet with $180.2 million in cash, cash equivalents, and available-for-sale securities at the end of Q3 2022 – Conference call today, …

Distribution channels: Business & Economy ...

Published on November 3, 2022 - 20:01 GMT

Apellis Announces Plans to Submit 24-Month Phase 3 Data to the FDA for Pegcetacoplan NDA for Geographic Atrophy (GA)

Inclusion of the 24-month data has the potential to strengthen the product profile at launch, with minimal impact to launch timing Submission will be a Major Amendment to the New Drug Application (NDA), extending the review period by three months with an …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on November 3, 2022 - 20:01 GMT

SurgePays Announces Third Quarter 2022 Earnings Release and Conference Call

BARTLETT, Tenn., Nov. 03, 2022 (GLOBE NEWSWIRE) -- SurgePays, Inc. (Nasdaq: SURG) (“SurgePays” or the “Company”), a technology and telecommunications company focused on the underbanked and underserved, announced today that management will host a live …

Distribution channels: Media, Advertising & PR ...

Published on November 3, 2022 - 20:01 GMT

TPI Composites, Inc. Announces Third Quarter 2022 Earnings Results – Announces Long-term Global Partnership with Vestas, Supply ...

SCOTTSDALE, Ariz., Nov. 03, 2022 (GLOBE NEWSWIRE) -- TPI Composites, Inc. (Nasdaq: TPIC), today reported financial results for the third quarter ended September 30, 2022. “In the third quarter, TPI delivered strong adjusted EBITDA growth and finished the …

Distribution channels: Business & Economy, Companies ...

Published on November 3, 2022 - 20:01 GMT

Collegium Reports Third Quarter 2022 Financial Results

– Generated Record Net Revenue of $127.0 Million – – Completed Xtampza® ER Contract Renegotiations, Confirmed Xtampza ER Gross-To-Net Will be Less Than 65% Beginning January 2023 – – Returned $10M in Capital to Shareholders Through Share Repurchases …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 3, 2022 - 20:01 GMT

Capricor Therapeutics to Present Third Quarter 2022 Financial Results and Recent Corporate Update on November 10

SAN DIEGO, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on November 3, 2022 - 20:01 GMT

MercadoLibre, Inc. Reports Third Quarter 2022 Financial Results

MONTEVIDEO, Uruguay, Nov. 03, 2022 (GLOBE NEWSWIRE) -- MercadoLibre, Inc. (Nasdaq: MELI) (http://www.mercadolibre.com), Latin America’s leading e-commerce technology company, today reported financial results for the quarter ended September 30, 2022, in a …

Distribution channels: Retail

Published on November 3, 2022 - 20:01 GMT

Kratos Reports Third Quarter 2022 Financial Results

SAN DIEGO, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (Nasdaq:KTOS), a leading National Security Solutions provider, today reported its third quarter 2022 financial results. For the third quarter of 2022, Kratos …

Distribution channels: Aviation & Aerospace Industry, Business & Economy ...

Published on November 3, 2022 - 20:01 GMT

MercadoLibre, Inc. Third Quarter 2022 Letter to Shareholders

Net Revenues of $2.7 billion, up 60.6% year-over-year on an FX neutral basis Income from operations of $296 million, with a 11.0% margin $32.2 billion Total Payment Volume, up 76.4% year-over-year on an FX neutral basis $8.6 billion Gross Merchandise …

Distribution channels: Business & Economy, Retail ...